Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Rapid City, SD Metro Edition
Focus: LIFE SCI
2.0%
Rapid City MSA unemployment
July 2026, among tightest metro markets nationally
66.5%
SD labor force participation
Down 1.7 pts YoY, 7th highest nationally
-900
SD private-sector jobs, August
Statewide net loss despite low unemployment
$74,360 vs $133,322
Biostatistician advertised pay, metro vs US
Metro down significantly, national up moderately
This Month's Takeaways
Metro median advertised pay for Biostatistician roles fell significantly even as national pay rose moderately to $133,322. Local employers risk losing quantitative talent to remote-eligible national postings if pay strategy doesn't account for this gap.
Advertised CRA pay rose moderately in the metro and significantly nationally, consistent with sustained clinical-stage hiring pressure. Expect continued upward pressure on offers for this role through year-end.
South Dakota shed 900 private-sector jobs in August even as unemployment held at 2.0%, suggesting broad hiring caution rather than loosening of the credentialed talent pool. Life Sci roles requiring regulatory, quality, or scientific credentials remain insulated from this softening.
Principal Scientist and VP Quality Assurance listings ($109K–$310K range) establish a visible in-state reference point for senior scientific and quality pay. Expect these postings to shape candidate expectations for comparable roles across the metro.
Local Labor Conditions
Rapid City MSA unemployment held near 2.0% through mid-2026, with civilian labor force participation and employer demand outpacing available credentialed workers across healthcare and technical occupations. Statewide, falling labor force participation (down 1.7 points year-over-year to 66.5%) and a net loss of 900 private-sector jobs in August point to a labor market that is tight on supply but cautious on employer expansion, a combination that sharpens competition for the scientific and regulatory talent Life Sci employers need most.
Leadership & Talent Implications
Metro-level scarcity in technical and healthcare occupations, paired with statewide hiring caution, means Life Sci leaders are competing for a shrinking pool of qualified candidates while facing internal pressure to justify every new requisition. Advertised pay for Biostatistician roles fell sharply in the metro even as national pay for the same role climbed, a divergence that complicates local benchmarking and increases the risk of losing candidates to remote national postings; Clinical Research Associate pay rose on both fronts, signaling where local competition is intensifying fastest. Organizations should evaluate whether local postings for quantitative and clinical roles are priced against the right comparison set — national remote-eligible pay, not historical metro medians — before finalizing offers this quarter.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | — | — | — | — No data | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $60,320 | $73,060 | $85,510 | ↑ Moderate increase | $90,956 | ↑ Significant increase |
| Lab Technician | $38,403 | $47,108 | $50,671 | ↑ Significant increase | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | — | — | — | — No data | $104,000 | → Stable |
| Clinical Data Manager | — | — | — | — No data | $123,031 | ↓ Moderate decline |
| Biostatistician | $58,356 | $74,360 | $108,363 | ↓ Significant decline | $133,322 | ↑ Moderate increase |
| Validation Engineer | — | — | — | — No data | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Expected
BLS releases September state unemployment data October 20 and metro-level data typically follows with a lag; watch for confirmation of whether the August private-sector job loss was a one-month blip or the start of a trend.
Emerging pressure point
Falling statewide labor force participation (down 1.7 points year-over-year) suggests the available candidate pool for specialized clinical and regulatory roles may keep shrinking, independent of overall job counts.
Worth watching
National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions rather than execution-critical science and quality roles; watch whether any displaced regulatory or CMC talent surfaces in regional or remote candidate searches reachable from Rapid City.
Potential inflection point
Discovery District's 2,800-worker life sciences build-out remains a 25-year horizon, offering no near-term headcount relief, but early site-selection or hiring announcements over the next 60 days would be the first concrete signal of accelerated timing.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.